SAFC to make virus-resistant cell lines
BioReliance and its parent company SAFC say they are working on viral-resistant cell lines that will prevent contamination in bioreactors.
Archives for June 23, 2014
Dispatches from BIO 2014
Kalon building $91m vaccine manufacturing facility in Texas for GSK partnership
Texas-based Kalon Biotherapeutics is in the process of building two new biomanufacturing facilities, including a $91m facility to produce flu vaccines for GlaxoSmithKline.